The House Energy and Commerce Committee passed 15 health-related bills approved by its health subcommittee last week, including bills that would reauthorize the Pandemic and All-Hazards Preparedness Act, Children’s Hospitals Graduate Medical Education Program, and key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act.  
 
The PAHPA reauthorization bills (H.R. 4421 and H.R. 4420) passed along party lines, with Democrats objecting to a lack of provisions to address drug shortages. The CHGME bill (H.R. 3887), also passed without Democratic support, would reauthorize payments to children’s hospitals that operate Graduate Medical Education programs for fiscal years 2024 through 2028 and prohibit payments to CHGME recipients that furnish gender-affirming procedures or drugs for minors. The Support for Patients and Communities Reauthorization Act (H.R. 4531), which passed with bipartisan support, would reauthorize key SUPPORT Act programs for patients with substance use disorder and permanently extend required Medicaid coverage for medication-assisted treatments. As amended and urged by the AHA, the bill also would permanently extend the option for state Medicaid programs to receive federal matching payments for SUD treatment provided in certain Institutions for Mental Disease for up to 30 days over a 12-month period. 

Related News Articles

Headline
Medicaid enrollment decreased 7.6% in fiscal year 2025 and is expected to be mostly flat in FY 2026, according to KFF’s annual Medicaid Budget Survey released…
Blog
Across the country, hospitals and health systems are working to meet the increasing demand for behavioral health care. As health needs evolve, many times the…
Headline
The Centers for Medicare & Medicaid Services is launching a new initiative for state Medicaid programs to purchase prescription drugs at prices aligned…
Headline
The AHA Nov. 7 released “Integrating Behavioral Health into Pediatric Care: Hospital-led Solutions to a Growing Crisis,” featuring five case studies on how the…
Headline
The White House announced today that it reached agreements with Eli Lilly and Novo Nordisk to align their drug prices with the lowest paid by other developed…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…